It has recently been reported that Merck Pharmaceutical Company’s leading lady, Dr. Julie Gerberding, has won yet another impressive title, being named Woman of the Year 2018 by the Healthcare Businesswomen’s Association (HBA).
Some of the achievements obtained by Dr. Gerberding noted by the HBA include: “Her leadership in modernizing the Centers for Disease Control and Prevention (CDC), executive vice president for strategic communications, global public policy and population health and chief patient officer, of Merck & Co., Inc., as president of Merck Vaccines… help(ing) make the company’s vaccines increasingly more available and affordable to people in emerging markets and some of the most resource-limited countries in the world….”
Since the Gardasil vaccine was approved while Gerberding was head of the CDC, many young girls who have received the Gardasil shots have gone into pre-mature menopause, suffering from Primary Ovarian Failure. These girls will never be able to bear children.
Some would ask the question: Since Gerberding is now in charge of “population health” at Merck and is being recognized as making “vaccines increasingly more available and affordable to people in emerging markets and some of the most resource-limited countries in the world,” was this part of the plan all along with the Gardasil vaccine? Others would ask, since the Gardasil vaccine is one of the most controversial vaccines in the world, with many lawsuits currently being litigated for injuries and deaths outside the U.S., and many countries outside the U.S. no longer recommending the vaccine, would it be more appropriate to name Dr. Julie Gerberding “one of the most evil people in medicine today,” as did the website Medicine News in 2016?